Clinical Trial Update: Safety of Lumiracoxib in Patients With Osteoarthritis [Phase 3]

View source ↗

Summary

The Phase 3 trial evaluating the safety of lumiracoxib in osteoarthritis has been completed. Specific safety outcomes are not provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Lumiracoxib (Prexige) (lumiracoxib)

Snippet

Sponsor: Novartis | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED